Product Information
Name:RET V804M-IN-1
Synonyms:
- 4-[5-(3-Pyridylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl]benzamide
Brand:Biosynth
Description:Selective inhibitor of the mutated RET variant RETV804M, which is the anticipated drug-resistant RET mutant that can occur in tumours treated with kinase inhibitors. The compound has a biochemical IC50 of 0.02 µM and selectivity for purified RETV804M over purified RET and KDR of 3.7 and 110, respectively. The efficacy of the compound was shown also in cell cultures with IC50 of 4.4 µM, and cell assay selectivity for RETV804M over RET and KDR of 0.89 and 2.3, respectively.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:344.37 g/mol
Formula:C19H16N6O
Purity:Min. 97 Area-%
Color/Form:White Powder
InChI:InChI=1S/C19H16N6O/c20-18(26)15-5-3-14(4-6-15)16-12-23-25-9-7-17(24-19(16)25)22-11-13-2-1-8-21-10-13/h1-10,12H,11H2,(H2,20,26)(H,22,24)
InChI key:InChIKey=LMGXQBQAUALFTB-UHFFFAOYSA-N
SMILES:NC(=O)c1ccc(-c2cnn3ccc(NCc4cccnc4)nc23)cc1
Technical inquiry about: RET V804M-IN-1
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.